The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement

21 Mar 2018 16:26

RNS Number : 5025I
Interserve PLC
21 March 2018
 

 

 

 

21 March 2018

 

UPDATE ON REFINANCING

 

Interserve announces that discussions with lenders and other financial stakeholders have continued to progress well, with agreement in principle on major commercial terms now reached. These commercial terms remain subject to credit approval from all providers before the new facilities are finalised. In addition, the lenders have agreed to extend the covenant test deferral date and the maturities of the financing facilities agreed in December 2017 to 30 April 2018 to enable the successful execution of all documentation required for the refinancing.

 

The additional facilities comprise cash facilities of £196.6m plus bonding facilities of up to £95m. These new facilities will mature in September 2021. Existing debt and private placement loan notes will be amended to be co-terminous with the new facilities. Borrowings made under the incremental short-term facilities agreed in December 2017 and which now expire on 30 April 2018 (under which the Company has drawn £45m of the revolving credit facility) will be repaid out of the new facilities, once these are in place. In total, this means that the company will have cash borrowing facilities of £834m immediately following the refinancing completion and through to September 2021, subject to certain step-downs in the new facilities over the period.

 

Pricing on both the new facilities, and the existing debt and bonding facilities have been renegotiated as part of the refinancing. It is anticipated that the total interest expense in 2018 will be approximately £56m of which circa £34m will be cash interest. The increased cost of bonding instruments already issued will be circa £3.2m, of which the cash impact is less than £1m.

 

Additionally, as part of the proposed deal terms, the company anticipates that it will issue warrants to the providers of the new cash and bonding facilities to buy shares at 10 pence per share (the nominal price of each share). If exercised, this would provide the warrant holders with an interest of up to 20% of the post-issue share capital.

 

We have, as part of this process, engaged extensively with the Trustee of the Interserve section of the Interserve Pension Scheme with respect to the new refinanced structure and their security protection. This has been agreed with them, subject to the finalisation of the required documentation.

 

 

Debbie White, Interserve's Chief Executive, said:

 

"Today's announcement is a significant milestone for Interserve and a major step in securing a firm financial platform to underpin the Group's future. We are encouraged by the support from our lenders in respect of these new facilities, which will allow the new management team to execute our business plan, focused on delivering a great service for customers, driving growth and restoring value."

 

Ends

 

 

 

Contact details:

Robin O'Kelly, Director of Communications +44 (0) 7786 702526

Rhys Jones, Head of PR, Interserve +44 (0) 7909 605336

Martin Robinson, Tulchan Communications +44 (0) 20 7353 4200

 

This announcement contains inside information

LEI: 549300MVYY4EZCRFHZ09

Classification: Inside information

 

About Interserve

 

Interserve is one of the world's foremost support services and construction companies. Our vision is to redefine the future for people and places. Everything we do is shaped by our core values. We are a leader in innovative and sustainable outcomes for our clients and a great place to work for our people. We offer advice, design, construction, equipment, facilities management and frontline public services. We are headquartered in the UK and listed in the FTSE. We have gross revenues of £3.7 billion and a workforce of circa 80,000 people worldwide.

www.interserve.com

 

For news follow @interservenews

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRSEDFMFFASEED
Date   Source Headline
9th Oct 20152:29 pmRNSDirector/PDMR Shareholding
7th Oct 20153:44 pmRNSDirector/PDMR Shareholding
18th Sep 20158:07 amRNSAnne Fahy appointed Non-Exec Director at SThree
14th Sep 20152:15 pmRNSDirector/PDMR Shareholding
9th Sep 20152:47 pmRNSDirector/PDMR Shareholding
4th Sep 20158:58 amRNSDirector/PDMR Shareholding
27th Aug 20159:29 amRNSPublication of Half-Year Report
25th Aug 201510:36 amRNSDirector/PDMR Shareholding
12th Aug 20152:33 pmRNSDirector/PDMR Shareholding - Correction
12th Aug 20157:00 amRNSHalf-Year Results
11th Aug 20152:31 pmRNSDirector/PDMR Shareholding
14th Jul 201512:07 pmRNSDirector/PDMR Shareholding
7th Jul 20157:00 amRNSTrading update
1st Jul 20159:46 amRNSBlocklisting Interim Review
23rd Jun 20157:00 amRNSInterserve to build Defence Rehabilitation Centre
17th Jun 201511:49 amRNSDirector/PDMR Shareholding
17th Jun 20157:00 amRNSInterserve hosts Capital Markets Day in London
2nd Jun 201512:31 pmRNSDirector/PDMR Shareholding
26th May 201511:30 amRNSDirector/PDMR Shareholding
12th May 20152:24 pmRNSResult of AGM
12th May 20157:00 amRNSTrading update
11th May 20154:04 pmRNSDirector/PDMR Shareholding
15th Apr 201511:36 amRNSDirector/PDMR Shareholding - Correction
14th Apr 201510:43 amRNSDirector/PDMR Shareholding
13th Apr 201510:51 amRNSDirector/PDMR Shareholding
1st Apr 20155:04 pmRNSDirector/PDMR Shareholding
31st Mar 20159:43 amRNSTotal Voting Rights
30th Mar 20152:50 pmRNSAnnual Financial Report
24th Mar 20153:21 pmRNSAdditional Listing
23rd Mar 20157:00 amRNSFinancial close reached on UK schools JV
13th Mar 201511:30 amRNSHolding(s) in Company
12th Mar 20157:00 amRNSInterserve JV wins GBP150m power plant contract
11th Mar 201510:12 amRNSDirector/PDMR Shareholding
4th Mar 20159:56 amRNSDirector/PDMR Shareholding
26th Feb 20157:05 amRNSChairman's intention to step down
26th Feb 20157:01 amRNSFinal Results
23rd Feb 20157:06 amRNSNick Salmon appointed Non-Exec Director of Acal
19th Feb 20157:00 amRNSNotice of Results
12th Feb 201511:43 amRNSDirector/PDMR Shareholding
2nd Feb 20154:04 pmRNSHolding(s) in Company
2nd Feb 20153:56 pmRNSHolding(s) in Company
27th Jan 201511:14 amRNSHolding(s) in Company
22nd Jan 20152:24 pmRNSHolding(s) in Company
16th Jan 20151:54 pmRNSDirector/PDMR Shareholding
7th Jan 20158:52 amRNSTrading Update
2nd Jan 20157:00 amRNSBlocklisting Interim Review
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 201410:33 amRNSHolding(s) in Company
18th Dec 201410:38 amRNSProbation and rehabilitation services contracts
17th Dec 20143:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.